Skip to main content
. 2023 Sep 9;7(22):7028–7044. doi: 10.1182/bloodadvances.2023010633

Table 3.

Risky health behaviors and hazard of subsequent all-cause and nonrecurrence–related late mortality

Variables of interest Crude HR (95% CI)
aHR (95% CI)
All-cause mortality All-cause mortality Nonrecurrence-related mortality
Ever smoke
 No Reference Reference Reference
 Yes 1.5 (1.4-1.8) 1.2 (1.1-1.5) 1.3 (1.0-1.8)
Smoking status
 Non-smoker Reference Reference Reference
 Former smoker 1.6 (1.4-1.8) 1.2 (1.1-1.5) 1.3 (1.0-1.8)
 Current smoker 1.4 (1.1-1.9) 1.7 (1.2-2.5) 1.6 (1.0-2.7)
Ever drink alcohol
 No Reference Reference Reference
 Yes 1.3 (1.1-1.5) 1.1 (0.9-1.3) 1.1 (0.9-1.4)
Heavy drinker
 No Reference Reference Reference
 Yes 0.9 (0.7-1.2) 1.4 (1.0-1.8) 1.4 (1.0-2.0)
Vigorous physical activity for at least 10 min at a time§
 Yes Reference Reference Reference
 No 1.5 (1.3-1.7) 1.2 (1.1-1.4) 1.2 (1.0-1.6)
Levels of vigorous exercise (total metabolic equivalent h/wk-1)§
 ≥ 9 MET h/wk-1 Reference Reference Reference
 3 to <9 MET h/wk-1 0.6 (0.4-0.8) 0.7 (0.5-1.0) 0.7 (0.6-0.1)
 0 MET h/wk-1 1.4 (1.2-1.7) 1.3 (1.1-1.7) 1.3 (1.0-1.7)

Bolded values indicate statistical significance (CI does not include 1).

Adjusted for sex, race/ethnicity, BMT era, time from BMT to study entry, age at BMT, primary diagnosis, stem cell source, disease status at BMT, BMT type, cGvHD, conditioning intensity, TBI, cyclophosphamide, nitrosoureas, busulfan, fludarabine, household income, educational status, chronic health conditions, mental health, physical activity status, alcohol consumption (ever), and total years of smoking. Survivors with missing smoking status were excluded from this analysis.

Adjusted for sex, race/ethnicity, BMT era, time from BMT to study entry, stem cell source, age at BMT, primary diagnosis, disease status at BMT, BMT type, cGvHD, conditioning intensity, TBI, cyclophosphamide, nitrosoureas, busulfan, fludarabine, household income, chronic health conditions, educational status, mental health, physical activity status, and smoking status (ever). Survivors with missing alcohol consumption status were missing from this analysis.

§

Adjusted for sex, race/ethnicity, BMT era, time from BMT to study entry, stem cell source, age at BMT, primary diagnosis, disease status at BMT, BMT type, cGvHD, conditioning intensity, TBI, cyclophosphamide, nitrosoureas, busulfan, fludarabine, household income, chronic health condition, educational status, mental health, anxiety from cancer treatment, smoking status (ever), and alcohol consumption (ever). Survivors with missing physical activity status were excluded from this analysis.